WSJ Your Money Briefing

Why are investors buzzing about Novo Nordisk’s Wegovy pill launch? And how has sentiment turned against software makers like Salesforce? Plus, what drove BlackRock’s asset pile to a record $14 trillion? Host Jack Pitcher discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Markets A.M. newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

How American oil companies are responding following U.S. action in Venezuela? And why were Constellation investors happy with lower beer sales? Plus, how can a big pharma deal help Eli Lilly compete in a new treatment area? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Markets A.M. newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Why did precious metals lose their sheen? And how much did holiday snowstorms hit airline stocks? Plus, how is BYD shaking up the EV race? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Markets A.M. newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

What did Micron’s earnings tell us about the AI boom? And what’s behind the corporate drama at Warner Bros. Discovery and Lululemon? Plus, does Medline's IPO splash bode well for future offerings? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Markets A.M. newsletter.  Learn more about your ad choices. Visit megaphone.fm/adchoices

What’s ailing Campbell’s soup? And why are investors jumpy again about AI? Plus, is Lululemon on the verge of making a comeback? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them.Sign up for the WSJ's free Markets A.M. newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices